Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Neurology Neurosurgery & Psychiatry

• Publication date

  2011-08-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/jnnp-2011-300616PMID 21865212
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An algorithm for genetic testing of frontotemporal lobar degeneration

  2011cited by this paper
• Disability and Survival of Multiple Sclerosis in Saskatoon, Saskatchewan

  2010cited by this paper
• Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts.

  2010cited by this paper
• New perspectives in the natural history of multiple sclerosis

  2010cited by this paper
• Causes of death among patients with multiple sclerosis

  2010cited by this paper
• Multiple sclerosis survival: a population‐based study in Sicily

  2010cited by this paper
• The natural history of secondary progressive multiple sclerosis

  2010cited by this paper
• Excess mortality and cause of death in a cohort of Norwegian multiple sclerosis patients

  2009cited by this paper
• The natural history of primary progressive multiple sclerosis

  2009cited by this paper
• Natural history of secondary-progressive multiple sclerosis

  2008cited by this paper
• Survival and cause of death in multiple sclerosis: a prospective population-based study

  2008cited by this paper
• Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway

  2008cited by this paper
• Making relative survival analysis relatively easy

  2007cited by this paper
• Long-term survival of patients with multiple sclerosis in West France

  2007cited by this paper
• Relative survival analysis in R

  2006cited by this paper
• Age at disability milestones in multiple sclerosis.

  2006cited by this paper
• Disability progression in multiple sclerosis is slower than previously reported

  2006cited by this paper
• Changes in the ascertainment of multiple sclerosis

  2005cited by this paper
• Trends in survival and cause of death in Danish patients with multiple sclerosis.

  2004cited by this paper
• Multiple sclerosis in Nord‐Trøndelag County, Norway: a prevalence and incidence study

  2003cited by this paper
• Survival of multiple sclerosis in Finland between 1964 and 1993

  2002cited by this paper
• Multiple sclerosis epidemiology in Sardinia: evidence for a true increasing risk

  2001cited by this paper
• Epidemiology of multiple sclerosis in US veterans. VIII. Long-term survival after onset of multiple sclerosis.

  2000cited by this paper
• The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis.

  1999cited by this paper
• Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK

  1998cited by this paper
• Recent Canadian Evidence on Job Quality by Firm Size

  1998cited by this paper
• Prognostic factors for survival in multiple sclerosis: a longitudinal, population based study in Møre and Romsdal, Norway.

  1995cited by this paper
• MS COSTAR: A computerized patient record adapted for clinical research purposes

  1994cited by this paper
• Survival of patients with multiple sclerosis in Denmark

  1994cited by this paper
• Life expectancy in patients attending multiple sclerosis clinics

  1992cited by this paper
• A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota

  1990cited by this paper
• Survival in multiple sclerosis.

  1989cited by this paper
• The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability.

  1989cited by this paper
• Prognostic factors for life expectancy in multiple sclerosis analysed by Cox-models.

  1988cited by this paper
• Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland.

  1987cited by this paper
• Prognostic indicators in multiple sclerosis

  1986cited by this paper
• Epidemiology of multiple sclerosis in US veterans

  1985cited by this paper
• A Cox regression model for the relative mortality and its application to diabetes mellitus survival data.

  1985cited by this paper
• New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

  1983cited by this paper

• Effects of Trans-spinal Direct Current Stimulation on Gait Function in People With Multiple Sclerosis.

  2025cites this paper
• Simultaneously Dealing With Immortal Time Bias and Residual Confounding: A Case Study of a High‐Dimensional Propensity Score Approach With a Nested Case–Control Framework in Multiple Sclerosis Research

  2025cites this paper
• The Phenotypes of Multiple Sclerosis Differ Significantly in Relative and Excess Mortality

  2025cites this paper
• Evaluating the Role of High‐Dimensional Proxy Data in Confounding Adjustment in Multiple Sclerosis Research: A Case Study

  2025cites this paper
• Cost-Minimization Analysis and Budget Impact Analysis About Subcutaneous Natalizumab in Relapsing-Remitting Multiple Sclerosis in Italy

  2025influential citation
• Review Article: Life Expectancy of Multiple Sclerosis in the US

  2024cites this paper
• Multiple sclerosis and vascular nexus: A systematic review and meta-analysis of incidence and mortality.

  2024cites this paper
• Multiple sclerosis in Colombia: A review of the literature

  2024cites this paper
• Real-World Safety and Effectiveness of Dimethyl Fumarate in Patients with MS: Results from the ESTEEM Phase 4 and PROCLAIM Phase 3 Studies with a Focus on Older Patients

  2024cites this paper
• Stable excess mortality in a multiple sclerosis cohort diagnosed 1970–2010

  2024cites this paper
• Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review

  2024cites this paper
• NMDA Receptor Antagonist Memantine Ameliorates Experimental Autoimmune Encephalomyelitis in Aged Rats

  2024cites this paper
• Dietary Supplementation with 23-Hydroxy Ursolic Acid Reduces the Severity and Incidence of Acute Experimental Autoimmune Encephalomyelitis (EAE) in a Murine Model of Multiple Sclerosis

  2024cites this paper
• Mortality of multiple sclerosis in Iceland population-based mortality of MS in incidence and prevalence cohorts

  2023influential citation
• The need for an individualized approach to what is considered a clinically significant reduction in seizure frequency: A patient's perspective

  2023cites this paper
• Survival and Its Correlates in Multiple Sclerosis Patients under a Universal Health Insurance Program in Taiwan: An 18-Year Nationwide Cohort Study

  2023cites this paper
• Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom

  2023influential citation
• Gut dysbiosis in autoimmune diseases: Association with mortality

  2023cites this paper
• Multiple sclerosis mortality in New Zealand: a nationwide prospective study

  2023cites this paper
• User appraisal of a booklet for advance care planning in multiple sclerosis: a multicenter, qualitative Italian study

  2023cites this paper
• The Heart–Brain Interplay in Multiple Sclerosis from Pathophysiology to Clinical Practice: A Narrative Review

  2023cites this paper
• Lived experience of persons with multiple sclerosis: A qualitative interview study

  2023cites this paper
• The impact of cognitive impairment on disease burden in Chinese patients with multiple sclerosis: A model simulation study.

  2023cites this paper
• Immunosenescence: the role of age in multiple sclerosis.

  2022cites this paper
• Does the inclusion of societal costs change the economic evaluations recommendations? A systematic review for multiple sclerosis disease

  2022cites this paper
• Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: A retrospective observational cohort study

  2022cites this paper
• The effect of nurse practitioner (NP-led) care on health-related quality of life in people with multiple sclerosis – a randomized trial

  2022cites this paper
• Association of multiple sclerosis with mortality in sepsis: a population-level analysis

  2022cites this paper
• Disease-Modifying Drugs for Multiple Sclerosis and Association With Survival

  2022cites this paper
• Stroke risk in multiple sclerosis: a critical appraisal of the literature

  2022cites this paper
• Incidence of malignant neoplasms and mortality in people affected by multiple sclerosis in the epoch of disease-modifying treatments: A population-based study on Tuscan residents.

  2022cites this paper
• The burden of sepsis in critically ill patients with multiple sclerosis: A population-based cohort study.

  2022cites this paper
• Study protocol on advance care planning in multiple sclerosis (ConCure-SM): intervention construction and multicentre feasibility trial

  2021cites this paper
• Identification of immune-associated gene signature and immune cell infiltration related to overall survival in progressive multiple sclerosis.

  2021cites this paper
• How have Economic Evaluations in Relapsing Multiple Sclerosis Evolved Over Time? A Systematic Literature Review

  2021cites this paper
• Breast Cancer Survival in Multiple Sclerosis

  2021cites this paper
• Effects of Age and Disease Duration on Excess Mortality in Patients With Multiple Sclerosis From a French Nationwide Cohort

  2021cites this paper
• Epidemiology of Multiple Sclerosis and Environmental Risk Factors

  2021cites this paper
• Temporal trends in the incidence and prevalence of Multiple Sclerosis in the Northwest of Spain.

  2021cites this paper
• Modeling the cost-effectiveness of prolonged-release fampridine for the treatment of walking impairment in patients with multiple sclerosis in Sweden

  2021cites this paper
• Comparative Effectiveness and Cost-Effectiveness of Natalizumab and Fingolimod in Patients with Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis in the United Kingdom

  2021cites this paper
• Promoting and measuring remyelination and neuroprotection in clinical trials of people with multiple sclerosis

  2021cites this paper
• Standardized mortality ratios in multiple sclerosis: Systematic review with meta‐analysis

  2021cites this paper
• An Innovative Approach to Modelling the Optimal Treatment Sequence for Patients with Relapsing–Remitting Multiple Sclerosis: Implementation, Validation, and Impact of the Decision-Making Approach

  2021cites this paper
• Living with severe multiple sclerosis: Cost-effectiveness of a palliative care intervention and cost of illness study.

  2021cites this paper
• Coexistence of Multiple Sclerosis and Alzheimer Disease Pathology: A Case Series

  2021cites this paper
• Apparent changes in the epidemiology and severity of multiple sclerosis

  2021cites this paper
• Colorectal Cancer Survival in Multiple Sclerosis

  2021cites this paper
• Incidence, prevalence and disability associated with neurological disorders in Italy between 1990 and 2019: an analysis based on the Global Burden of Disease Study 2019

  2021cites this paper
• The nature of genetic and environmental susceptibility to multiple sclerosis

  2021cites this paper
• ASSESSMENT OF COMORBIDITY BURDEN IN PERSONS WITH MULTIPLE SCLEROSIS: OBSERVATIONAL STUDY BASED ON BELGRADE POPULATION REGISTRY DATA

  2020cites this paper
• Frailty in ageing persons with multiple sclerosis

  2020cites this paper
• New epidemiological data of multiple sclerosis, the impact of psychopathological symptoms on the health-related quality of life of multiple sclerosis patients

  2020cites this paper
• Evaluating the Risk of Macrovascular Events and Mortality Among People With Multiple Sclerosis in England.

  2020cites this paper
• A note on the applicability of the standard nonparametric maximum likelihood estimator for combined incident and prevalent cohort data

  2020cites this paper
• Multiple cause of death analysis in multiple sclerosis

  2020cites this paper
• Risk of Mortality in Immigrants with Multiple Sclerosis in Ontario, Canada

  2020cites this paper
• Immunmediierte Erkrankungen des Nervensystems

  2020cites this paper
• Informing Medication Discontinuation Decisions among Older Adults with Relapsing-Onset Multiple Sclerosis

  2020cites this paper
• Dealing with Treatment-confounder Feedback and Sparse Follow-up in Longitudinal studies - Application of a Marginal Structural Model in a Multiple Sclerosis Cohort.

  2020cites this paper
• Safety of dimethyl fumarate for multiple sclerosis: A systematic review and meta-analysis.

  2020cites this paper
• Immunosenescence: the role of age in multiple sclerosis.

  2020cites this paper
• The Nature of Genetic Susceptibility to Multiple Sclerosis

  2020cites this paper
• Coexistence of Multiple Sclerosis and Alzheimer's disease: A review.

  2019cites this paper
• Multiple sclerosis: effect of beta interferon treatment on survival.

  2019cites this paper
• Age-related decreases in relapses among adults with relapsing-onset multiple sclerosis

  2019cites this paper
• Genetic susceptibility to multiple sclerosis: interactions between conserved extended haplotypes of the MHC and other susceptibility regions

  2019cites this paper
• Prodrome in relapsing‐remitting and primary progressive multiple sclerosis

  2019cites this paper
• Histoire naturelle de la sclérose en plaques

  2019cites this paper
• The epidemiology of multiple sclerosis: new data in mortality and cognitive impairment from Hungary

  2019influential citation
• The real p(atient) value

  2019cites this paper
• Epidemiology and treatment of multiple sclerosis in elderly populations

  2019cites this paper
• Causes that Contribute to the Excess Mortality Risk in Multiple Sclerosis: A Population-Based Study

  2019cites this paper
• Team-Based Rehabilitation: Functional and Quality of Life Outcomes

  2019cites this paper
• The use of brain stimulation in the rehabilitation of walking disability in patients with multiple sclerosis: A randomized double-blind clinical trial study

  2019cites this paper
• A contemporary study of mortality in the multiple sclerosis population of south east Wales.

  2018cites this paper
• Establishing the Incidence and Prevalence of Multiple Sclerosis in Saskatchewan

  2018influential citation
• Multiple sclerosis

  2018cites this paper
• The Use of Digital and Remote Communication Technologies as a Tool for Multiple Sclerosis Management: Narrative Review

  2018cites this paper
• Predictors for Employment Status in People With Multiple Sclerosis: A 10-Year Longitudinal Observational Study.

  2018cites this paper
• Common comorbidities and survival in MS: Risk for stroke, type 1 diabetes and infections.

  2018cites this paper
• Psychiatric comorbidity increases mortality in immune-mediated inflammatory diseases.

  2018cites this paper
• Perspectives on walking from people with multiple sclerosis and reactions to video self-observation

  2018cites this paper
• Comorbidity in multiple sclerosis: implications for patient care

  2017cites this paper
• Role of intestinal microbiota in the development of multiple sclerosis

  2017cites this paper
• Signes et symptômes de la sclérose en plaques

  2017cites this paper
• A clinical and electrophysiological study of the effects of 4-aminopyridine on upper limb impairment in multiple sclerosis

  2017cites this paper
• Role of intestinal microbiota in the development of multiple sclerosis.

  2017cites this paper
• Women and Neurological Disability: End-of-Life Care and Mortality in Women with MS

  2017cites this paper
• Clinical effectiveness and cost-effectiveness of beta-interferon and glatiramer acetate for treating multiple sclerosis: systematic review and economic evaluation.

  2017influential citation
• Excess mortality among patients with multiple sclerosis in Denmark has dropped significantly over the past six decades: a population based study

  2017cites this paper
• Mortality trends for multiple sclerosis patients in Sweden from 1968 to 2012

  2017influential citation
• Patient-reported outcomes and survival in multiple sclerosis: A 10-year retrospective cohort study using the Multiple Sclerosis Impact Scale–29

  2017cites this paper
• Causes of death in critically ill multiple sclerosis patients

  2017cites this paper
• La sclérose en plaques au Canada, 2011-2031 : résultats d’une étude de modélisation par microsimulation des répercussions épidémiologiques et économiques

  2017cites this paper
• ESPEN guideline clinical nutrition in neurology.

  2017cites this paper
• Cost-utility of First-line Disease-modifying Treatments for Relapsing-Remitting Multiple Sclerosis.

  2017cites this paper
• Hormonal Contraception and the Development of Autoimmunity: A Review of the Literature

  2017influential citation
• Predictors of Mortality in Veterans with Multiple Sclerosis in an Outpatient Clinic Setting.

  2017cites this paper
• Multiple sclerosis in Canada 2011 to 2031: results of a microsimulation modelling study of epidemiological and economic impacts.

  2017cites this paper